Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared To Labetalol In Patients With Acute Stroke

Links shared publicly online about this topic.

  • 1,460
    total visits

Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared To Labetalol In Patients With Acute Stroke

medicalnewstoday.com —

EKR Therapeutics, Inc., a specialty pharmaceutical company commercializing acute-care hospital products, today said that interim study data1 demonstrate that Cardene® I.V. (nicardip

View full resource at medicalnewstoday.com

Tags: Stroke, Thrombotic Event, Hospital, Pharma, Beta Blocker, Normodyne, Trandate, Hospitals

  • Share

Most Recently Shared on January 13, 2010 at 6:36 am By:

Health_Feed Health Feed

Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared To Labetalol In Patien... http://ow.ly/16kjF6

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

medical_tweets medical_tweets

Advertisement